Home/Filings/4/0001179110-18-003320
4//SEC Filing

Cox Christopher T 4

Accession 0001179110-18-003320

CIK 0001113481other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 5:17 PM ET

Size

7.6 KB

Accession

0001179110-18-003320

Insider Transaction Report

Form 4
Period: 2018-02-28
Cox Christopher T
EVP & Chief Corp. Dev. Officer
Transactions
  • Award

    Common Stock

    2018-03-01+15,00060,943 total
  • Award

    Common Stock

    2018-02-28$26.02/sh+330$8,58745,943 total
Holdings
  • Common Stock

    (indirect: See footnote)
    171,155
Footnotes (3)
  • [F1]Acquired pursuant to The Medicines Company Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period beginning September 1, 2017 and ending February 28, 2018. In accordance with the terms of the ESPP, these shares were purchased based on 85% of the fair market value closing price of the issuer's common stock on February 28, 2018.
  • [F2]Shares of restricted stock vest in 25% increments on each anniversary of the date of grant, until fully vested.
  • [F3]The reporting person holds a power of attorney with respect to this account. Members of the reporting person's immediate family may be considered to have a pecuniary interest in this account. The reporting person disclaims beneficial ownership of the shares held by this account except to the extent of his pecuniary interest therein.

Issuer

MEDICINES CO /DE

CIK 0001113481

Entity typeother

Related Parties

1
  • filerCIK 0001557341

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:17 PM ET
Size
7.6 KB